November 04, 2019
MyoKardia
MyoKardia Reports Third Quarter 2019 Financial Results
November 04, 2019
Revolution Medicines
Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510
November 04, 2019
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
November 01, 2019
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
October 31, 2019
Agios Pharmaceuticals
Agios Reports Business Highlights and Third Quarter 2019 Financial Results